...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

Seeing that ZHCLF shares are transacted via Canadian brokerage houses,

I don't see that as relevant.

As RBC explains here....

....In general, a security that trades only on OTC markets is a non-qualified investment....

But, read Zenith's Q&A #8.

 

Share
New Message
Please login to post a reply